Editor's Choice Articles are selected based on suggestions from Cancers’ Academic Editors worldwide. The Editors select a small number of recently published articles that they consider particularly interesting to our readers or important in their respective fields of research. You are welcome to read the Editor's Choice Articles related to molecular cancer biology, a curated list of high-quality articles from 2022 to 2023 in Cancers (ISSN: 2072-6694). The list of relevant papers can be seen below. The full list of Editor's Choice Articles can be viewed at the following link: https://www.mdpi.com/journal/cancers/editors_choice.

“NKG2A Immune Checkpoint in Vδ2 T Cells: Emerging Application in Cancer Immunotherapy”
by Valentina Cazzetta, Delphine Depierreux, Francesco Colucci, Joanna Mikulak and Domenico Mavilio
Cancers 2023, 15(4), 1264; https://doi.org/10.3390/cancers15041264
Available online: https://www.mdpi.com/2072-6694/15/4/1264

“Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer”
by Flavia Jacobs, Elisa Agostinetto, Chiara Miggiano, Rita De Sanctis, Alberto Zambelli and Armando Santoro
Cancers 2023, 15(11), 2933; https://doi.org/10.3390/cancers15112933
Available online: https://www.mdpi.com/2072-6694/15/11/2933

“Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1”
by Negar Khazan, Emily R. Quarato, Niloy A. Singh, Cameron W. A. Snyder, Taylor Moore, John P. Miller, Masato Yasui, Yuki Teramoto, Takuro Goto, Sabeeha Reshi et al.
Cancers 2023, 15(13), 3432; https://doi.org/10.3390/cancers15133432
Available online: https://www.mdpi.com/2072-6694/15/13/3432

“Analysis of the Gut Microbiome and Dietary Habits in Metastatic Melanoma Patients with a Complete and Sustained Response to Immunotherapy”
by Marin Golčić, Luka Simetić, Davorin Herceg, Krešimir Blažičević, Gordana Kenđel Jovanović, Ivan Dražić, Andrej Belančić, Nataša Skočibušić, Dora Palčevski, Igor Rubinić et al.
Cancers 2023, 15(11), 3052; https://doi.org/10.3390/cancers15113052
Available online: https://www.mdpi.com/2072-6694/15/11/3052

“The Influence of the Microbiome on Immunotherapy for Gastroesophageal Cancer”
by Neda Dadgar, Vinay Edlukudige Keshava, Moses S. Raj and Patrick L. Wagner
Cancers 2023, 15(18), 4426; https://doi.org/10.3390/cancers15184426
Available online: https://www.mdpi.com/2072-6694/15/18/4426

“Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer”
by Ching-Hung Hsieh, Cheng-Zhe Jian, Liang-In Lin, Guan-Sian Low, Ping-Yun Ou, Chiun Hsu and Da-Liang Ou
Cancers 2022, 14(2), 294; https://doi.org/10.3390/cancers14020294
Available online: https://www.mdpi.com/2072-6694/14/2/294

“Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy”
by Arsela Prelaj, Mattia Boeri, Alessandro Robuschi, Roberto Ferrara, Claudia Proto, Giuseppe Lo Russo, Giulia Galli, Alessandro De Toma, Marta Brambilla, Mario Occhipinti et al.
Cancers 2022, 14(2), 435; https://doi.org/10.3390/cancers14020435
Available online: https://www.mdpi.com/2072-6694/14/2/435

“The Role of Bruton’s Kinase Inhibitors in Chronic Lymphocytic Leukemia: Current Status and Future Directions”
by Tadeusz Robak, Magda Witkowska and Piotr Smolewski
Cancers 2022, 14(3), 771; https://doi.org/10.3390/cancers14030771
Available online: https://www.mdpi.com/2072-6694/14/3/771

“Emerging CAR T Cell Strategies for the Treatment of AML”
by Paresh Vishwasrao, Gongbo Li, Justin C. Boucher, D. Lynne Smith and Susanta K. Hui
Cancers 2022, 14(5), 1241; https://doi.org/10.3390/cancers14051241
Available online: https://www.mdpi.com/2072-6694/14/5/1241

“Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis”
by Alessandro Rizzo, Antonio Cusmai, Francesco Giovannelli, Silvana Acquafredda, Lucia Rinaldi, Andrea Misino, Elisabetta Sara Montagna, Valentina Ungaro, Mariagrazia Lorusso and Gennaro Palmiotti
Cancers 2022, 14(6), 1404; https://doi.org/10.3390/cancers14061404
Available online: https://www.mdpi.com/2072-6694/14/6/1404

“Mesothelin: An Immunotherapeutic Target beyond Solid Tumors”
by Joshua R. Faust, Darcy Hamill, Edward Anders Kolb, Anilkumar Gopalakrishnapillai and Sonali P. Barwe
Cancers 2022, 14(6), 1550; https://doi.org/10.3390/cancers14061550
Available online: https://www.mdpi.com/2072-6694/14/6/1550

“Advances in Immunotherapy for the Treatment of Adult Glioblastoma: Overcoming Chemical and Physical Barriers”
by Mirna Lechpammer, Rohan Rao, Sanjit Shah, Mona Mirheydari, Debanjan Bhattacharya, Abigail Koehler, Donatien Kamdem Toukam, Kevin J. Haworth, Daniel Pomeranz Krummel and Soma Sengupta
Cancers 2022, 14(7), 1627; https://doi.org/10.3390/cancers14071627
Available online: https://www.mdpi.com/2072-6694/14/7/1627

“Expression of CD47 and SIRPα Macrophage Immune-Checkpoint Pathway in Non-Small-Cell Lung Cancer ”
by Alexandra Giatromanolaki, Achilleas Mitrakas, Ioannis Anestopoulos, Andreas Kontosis, Ioannis M. Koukourakis, Aglaia Pappa, Mihalis I. Panayiotidis and Michael I. Koukourakis
Cancers 2022, 14(7), 1801; https://doi.org/10.3390/cancers14071801
Available online: https://www.mdpi.com/2072-6694/14/7/1801

“Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review”
by Biagio Barone, Armando Calogero, Luca Scafuri, Matteo Ferro, Giuseppe Lucarelli, Erika Di Zazzo, Enrico Sicignano, Alfonso Falcone, Lorenzo Romano, Luigi De Luca et al.
Cancers 2022, 14(10), 2545; https://doi.org/10.3390/cancers14102545
Available online: https://www.mdpi.com/2072-6694/14/10/2545

“Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor Reactivity”
by Yan-Ruide Li, James Brown, Yanqi Yu, Derek Lee, Kuangyi Zhou, Zachary Spencer Dunn, Ryan Hon, Matthew Wilson, Adam Kramer, Yichen Zhu et al.
Cancers 2022, 14(11), 2749; https://doi.org/10.3390/cancers14112749
Available online: https://www.mdpi.com/2072-6694/14/11/2749

“Interconnected Adaptive Responses: A Way Out for Cancer Cells to Avoid Cellular Demise”
by Gabriella D’Orazi and Mara Cirone
Cancers 2022, 14(11), 2780; https://doi.org/10.3390/cancers14112780
Available online: https://www.mdpi.com/2072-6694/14/11/2780

“Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors”
by Qiuqiang Chen, Lingeng Lu and Wenxue Ma
Cancers 2022, 14(23), 5983; https://doi.org/10.3390/cancers14235983
Available online: https://www.mdpi.com/2072-6694/14/23/5983

“CAR-NK as a Rapidly Developed and Efficient Immunotherapeutic Strategy against Cancer”
by Marta Włodarczyk and Beata Pyrzynska
Cancers 2023, 15(1), 117; https://doi.org/10.3390/cancers15010117
Available online: https://www.mdpi.com/2072-6694/15/1/117

You are invited to view and submit relevant papers to the journal Cancers at the following link:

https://www.mdpi.com/journal/cancers.

Cancers Editorial Office